Myomo (FRA:0M61) YoY EBITDA Growth : 2.06% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Myomo YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Myomo's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 2.06%.

Myomo's EBITDA per Share for the three months ended in Mar. 2024 was €-0.10.

Myomo YoY EBITDA Growth Historical Data

The historical data trend for Myomo's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Myomo YoY EBITDA Growth Chart

Myomo Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

22.47

84.40

44.37

10.08

82.30

Myomo Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															71.88	91.78	86.95	76.54	2.06

Myomo YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Myomo's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-0.24	-	-1.356)	/	\| -1.356 \|
=	82.30 %

Myomo's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(-0.095	-	-0.097)	/	\| -0.097 \|
=	2.06 %

Myomo YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Myomo's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Myomo (FRA:0M61) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Myomo Inc (FRA:0M61) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

MYO:USA 0M61:Germany

Address

137 Portland Street, 4th Floor, Boston, MA, USA, 02114

Website

https://www.myomo.com

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the device to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Myomo (FRA:0M61) Headlines

No Headlines